These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38325369)
1. Fluorinated cGAMP analogs, which act as STING agonists and are not cleavable by poxins: Structural basis of their function. Klima M; Dejmek M; Duchoslav V; Eisenreichova A; Sala M; Chalupsky K; Chalupska D; Novotná B; Birkuš G; Nencka R; Boura E Structure; 2024 Apr; 32(4):433-439.e4. PubMed ID: 38325369 [TBL] [Abstract][Full Text] [Related]
2. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling. Eaglesham JB; Pan Y; Kupper TS; Kranzusch PJ Nature; 2019 Feb; 566(7743):259-263. PubMed ID: 30728498 [TBL] [Abstract][Full Text] [Related]
3. Structures of diverse poxin cGAMP nucleases reveal a widespread role for cGAS-STING evasion in host-pathogen conflict. Eaglesham JB; McCarty KL; Kranzusch PJ Elife; 2020 Nov; 9():. PubMed ID: 33191912 [TBL] [Abstract][Full Text] [Related]
4. Novel Poxin Stable cGAMP-Derivatives Are Remarkable STING Agonists. Stazzoni S; Böhmer DFR; Hernichel F; Özdemir D; Pappa A; Drexler D; Bauernfried S; Witte G; Wagner M; Veth S; Hopfner KP; Hornung V; König LM; Carell T Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202207175. PubMed ID: 35876840 [TBL] [Abstract][Full Text] [Related]
6. The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibition. Hall J; Ralph EC; Shanker S; Wang H; Byrnes LJ; Horst R; Wong J; Brault A; Dumlao D; Smith JF; Dakin LA; Schmitt DC; Trujillo J; Vincent F; Griffor M; Aulabaugh AE Protein Sci; 2017 Dec; 26(12):2367-2380. PubMed ID: 28940468 [TBL] [Abstract][Full Text] [Related]
7. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis. Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING). Xie X; Liu J; Wang X Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423 [TBL] [Abstract][Full Text] [Related]
9. cGAMP-activated cGAS-STING signaling: its bacterial origins and evolutionary adaptation by metazoans. Patel DJ; Yu Y; Xie W Nat Struct Mol Biol; 2023 Mar; 30(3):245-260. PubMed ID: 36894694 [TBL] [Abstract][Full Text] [Related]
10. Assessing the cGAS-cGAMP-STING Activity of Cancer Cells. Pépin G; Gantier MP Methods Mol Biol; 2018; 1725():257-266. PubMed ID: 29322423 [TBL] [Abstract][Full Text] [Related]
11. SMPDL3A is a cGAMP-degrading enzyme induced by LXR-mediated lipid metabolism to restrict cGAS-STING DNA sensing. Hou Y; Wang Z; Liu P; Wei X; Zhang Z; Fan S; Zhang L; Han F; Song Y; Chu L; Zhang C Immunity; 2023 Nov; 56(11):2492-2507.e10. PubMed ID: 37890481 [TBL] [Abstract][Full Text] [Related]
12. The Chemistry of the Noncanonical Cyclic Dinucleotide 2'3'-cGAMP and Its Analogs. Schwede F; Genieser HG; Rentsch A Handb Exp Pharmacol; 2017; 238():359-384. PubMed ID: 27392950 [TBL] [Abstract][Full Text] [Related]